Newsroom

Catch up on news from Cerapedics and our developments. Follow us on LinkedIn and X to keep up with all of the latest news.

February 23, 2022 Cerapedics Completes Enrollment of Pivotal U.S. FDA IDE Study for its P-15L Bone Graft Arrow icon
August 17, 2021 Cerapedics Announces Publication of Results of Study Evaluating the Cost-Effectiveness of i-FACTOR vs. Local Autologous Bone in ACDF Surgery Arrow icon
April 29, 2021 Cerapedics Announces FDA Breakthrough Device Designation Granted for P-15L Bone Graft for the Treatment of Degenerative Disc Disease Arrow icon
November 5, 2020 Cerapedics Announces Commercial Launch of i-FACTOR®+ Matrix in Canada Arrow icon
September 15, 2020 Cerapedics Announces Canadian Approval of its next-generation bone graft Arrow icon
July 22, 2020 Cerapedics Announces FDA approval of an IDE supplement Arrow icon
May 19, 2020 Cerapedics Announces Results from Clinical Trial of i-FACTOR® Peptide Enhanced Bone Graft in Lumbar Fusion Surgery Arrow icon
November 18, 2019 Cerapedics Announces FDA Approval of PMA Supplement Based on Two-Year Clinical Data Arrow icon
July 8, 2019 Cerapedics Announces Expansion of Colorado Headquarters Arrow icon
June 24, 2019 New V.P. of Clinical and Market Development Arrow icon